Lumason for Vesicoureteral Reflux

This trial tests a new method for detecting kidney scarring using a special ultrasound with a dye called Lumason (sulfur hexafluoride lipid-type A microspheres). The goal is to develop a safer, radiation-free way to diagnose kidney issues, potentially replacing more expensive and risky tests that involve radiation and possible allergic reactions. This method could benefit patients scheduled for a DMSA scan for kidney problems who do not have major kidney abnormalities or severe heart and lung diseases. As a Phase 1 trial, the research focuses on understanding how this new diagnostic method works in people, offering participants the chance to be among the first to benefit from this innovative approach.

Research has shown that Lumason, a substance used to enhance medical images, is generally safe. In a study involving over 6,000 children, researchers reported no negative reactions. Another study, which examined more than 2,000 uses of Lumason, identified only one minor side effect. These findings suggest that Lumason is safe for most people.

Unlike the standard treatment options for vesicoureteral reflux, which often involve antibiotics or surgery, Lumason is unique because it uses a contrast-enhanced ultrasound (CEUS) technique. This method allows doctors to get a clearer image of the urinary tract, potentially leading to more accurate diagnoses without the need for radiation exposure, which is common in traditional imaging methods like X-rays or CT scans. Researchers are excited about Lumason because it offers a non-invasive, safer alternative that might improve the comfort and safety of imaging for patients, especially children.

Research has shown that Lumason effectively helps detect vesicoureteral reflux (VUR), a condition where urine flows backward from the bladder to the kidneys, when used in contrast-enhanced ultrasound. In this trial, participants will undergo a contrast-enhanced ultrasound using Lumason. Studies involving over 6,000 children demonstrated that Lumason worked well without any reported side effects. This contrast agent enhances the clarity of body structures during ultrasound exams. Animal studies have found it safe and reliable, and it does not significantly increase the risk of serious reactions in humans. Overall, Lumason has a strong record of safety and effectiveness in improving diagnostic imaging.¹²⁶⁷⁸